Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine

This page shows you your search results in order of relevance. This is page number 4.

Order by Relevance | Date

Total 1783 results found since Jan 2013.

Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2  vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | DOI:10.1016/j.ejim.2022.07.022
Source: Herpes - August 5, 2022 Category: Infectious Diseases Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research

The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis
CONCLUSION: Pharmacist involvement as immunizer, advocator, or both roles has favorable effects on immunization uptake, especially with influenza vaccines in the United States and some high-income countries. As the practice of pharmacists in immunization has been expanded globally, further research on investigating the impact of pharmacist involvement in immunization in other countries, especially developing ones, is warranted.PMID:35961937 | DOI:10.1016/j.japh.2022.06.008
Source: Herpes - August 12, 2022 Category: Infectious Diseases Authors: Lan My Le Sajesh K Veettil Daniel Donaldson Warittakorn Kategeaw Raymond Hutubessy Philipp Lambach Nathorn Chaiyakunapruk Source Type: research

Corneal Complications after COVID-19 Vaccination: A Systemic Review
J Clin Med. 2022 Nov 18;11(22):6828. doi: 10.3390/jcm11226828.ABSTRACTMultiple vaccines are now being used across the world, and several studies have described cases of corneal graft rejection following the administration of the COVID-19 vaccine. The purpose of this article is to review the corneal adverse event that occurred following COVID-19 vaccine administration. The literature search was conducted in March 2022 using MEDLINE, PubMed, and the Cochrane Database of Systematic Reviews. A total of 27 articles, including 37 cases, have documented corneal adverse events that occurred following COVID-19 vaccination. The mean...
Source: Herpes - November 26, 2022 Category: Infectious Diseases Authors: Li-Ying Huang Chun-Chi Chiang You-Ling Li Hung-Yin Lai Yi-Ching Hsieh Ying-Hsuen Wu Yi-Yu Tsai Source Type: research

Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis
CONCLUSIONS: Only 1 in 2 individuals showed a willingness to be vaccinated against HZ. The willingness rate was the highest in the Eastern Mediterranean Region. Our findings show the critical role HCWs play in promoting HZ vaccination. Monitoring HZ vaccination willingness is necessary to inform public health decision-making. These findings provide critical insights for designing future life-course immunization programs.PMID:36892937 | DOI:10.2196/43893
Source: Herpes - March 9, 2023 Category: Infectious Diseases Authors: Qiang Wang Liuqing Yang Lan Li Chang Liu Hui Jin Leesa Lin Source Type: research

Pediatric herpes zoster ophthalmicus: a systematic review
CONCLUSION: HZO occurs in both healthy and immunocompromised children. Recognizing this treatable condition is essential for reducing ocular and systemic morbidity. Long-term follow-up and assessments of the impact on health in adulthood are lacking. More systematic study is needed to determine the incidence of HZO in children and appropriate diagnostic and treatment protocols for the care of pediatric patients with HZO.PMID:36949170 | DOI:10.1007/s00417-023-06033-0
Source: Herpes - March 23, 2023 Category: Infectious Diseases Authors: Farida E Hakim Kamran Riaz Asim Farooq Source Type: research

Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65  years: a systematic review
Geroscience. 2023 Jun 3. doi: 10.1007/s11357-023-00807-4. Online ahead of print.ABSTRACTThis systematic review aims to summarize the impact of vaccination against influenza, shingles, and pneumococcus on the incidence on the risk of cardiovascular events in the elderly. This protocol was developed in accordance with PRISMA guidelines. We conducted a literature search and identified all relevant articles published regarding the matter up to September 2022. We retrieved 38 studies (influenza vaccine = 33, pneumococcal vaccine = 5, and zoster vaccine = 2). A total of 28 and 2 studies have shown that influenza and pneumococcal...
Source: Herpes - June 3, 2023 Category: Infectious Diseases Authors: Alexandra Addario Thomas C élarier Bienvenu Bongue Nathalie Barth Ga ëtan Gavazzi Elisabeth Botelho-Nevers Source Type: research

Shingles Becoming More Prominent In All Age Groups
var videoCanvas = new WNVideoWidget("WNVideoCanvas", "wnVideo_8121511");videoCanvas.SetWidth(385);videoCanvas.SetHeight(288);videoCanvas.SetVariable("clipId", "8121511");videoCanvas.SetVariable("transportShareButtons", "cc");videoCanvas.SetReportingKeywords("CBS.BOSTON");videoCanvas.SetAdvertisingZone("CBS.BOSTON/worldnowplayer");videoCanvas.SetVariable("offFaceColor", "afaeae");videoCanvas.SetVariable("overFaceColor", "ffffff");videoCanvas.SetVariable("backgroundColors", "212121,676767,676767,212121");videoCanvas.SetVariable("backgroundAlphas", "0,0,0,0");videoCanvas.SetVariable("backgroundRatios", "0,25,130,255");videoCa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 1, 2013 Category: Consumer Health News Authors: stevesaleeba Tags: Health Seen On WBZ-TV Syndicated Local Watch Listen Paula Ebben Shingles Source Type: news

A population based study of the epidemiology of Herpes Zoster and its complications
Conclusions: Extrapolating to the entire Israeli population, we estimate over 24,000 new cases of HZ and 1250 new cases of PHN each year. Cost-effectiveness analysis should be performed to determine the threshold age for vaccination against HZ.
Source: Journal of Infection - July 18, 2013 Category: Infectious Diseases Authors: Dahlia Weitzman, Oren Shavit, Michal Stein, Raanan Cohen, Gabriel Chodick, Varda Shalev Tags: Viruses and Viral Diseases Source Type: research

Vaccines for preventing herpes zoster in older adults.
CONCLUSIONS: Herpes zoster vaccine is effective in preventing herpes zoster disease. Although vaccine benefits are larger in the younger age group (60 to 69 years), this is also the age group with more adverse events. In general, zoster vaccine is well tolerated; it produces few systemic adverse events and injection site adverse effects of mild to moderate intensity. PMID: 25055074 [PubMed - as supplied by publisher]
Source: Sao Paulo Medical Journal - July 24, 2014 Category: Journals (General) Authors: Gagliardi AM, Silva BN, Torloni MR, Soares BG Tags: Sao Paulo Med J Source Type: research

Systematic review of incidence and complications of herpes zoster: towards a global perspective
Conclusions HZ is a significant global health burden that is expected to increase as the population ages. Future research with rigorous methods is important.
Source: BMJ Open - June 10, 2014 Category: Journals (General) Authors: Kawai, K., Gebremeskel, B. G., Acosta, C. J. Tags: Open access, Epidemiology, Global health, Infectious diseases Research Source Type: research

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries
Conclusions: While HZ vaccination is mostly considered cost-effective, cost-effectiveness of varicella vaccination primarily depends on the in- or exclusion of exogenous boosting in the model. As a consequence, clarification on the role of exogenous boosting is crucial for decision-making regarding varicella vaccination.
Source: BMC Public Health - June 5, 2015 Category: Consumer Health News Authors: Oliver DammBernhard UltschJohannes HornRafael MikolajczykWolfgang GreinerOle Wichmann Source Type: research

Live attenuated herpes zoster vaccine for HIV‐infected adults
ConclusionsIt is recommended that LAHZV be administered to HIV‐infected adults with a CD4 count above 200 cells/μL, the same CD4 threshold used for other live attenuated viral vaccines.
Source: HIV Medicine - August 29, 2015 Category: Infectious Diseases Authors: SD Shafran Tags: Viewpoints on HIV Research Source Type: research

Vaccines for preventing herpes zoster in older adults.
CONCLUSIONS: Herpes zoster vaccine is effective in preventing herpes zoster disease and this protection can last three years. In general, zoster vaccine is well tolerated; it produces few systemic adverse events and injection site adverse events of mild to moderate intensity.There are studies of a new vaccine (with a VZV glycoproteic fraction plus adjuvant), which is currently not yet available for clinical use. PMID: 26937872 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - March 3, 2016 Category: Journals (General) Authors: Gagliardi AM, Andriolo BN, Torloni MR, Soares BG Tags: Cochrane Database Syst Rev Source Type: research